Literature DB >> 23430493

Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease.

Mónica Yasmín Niño1, Heidi Eliana Mateus, Dora Janeth Fonseca, Marian A Kroos, Sandra Yaneth Ospina, Juan Fernando Mejía, Jesús Alfredo Uribe, Arnold J J Reuser, Paul Laissue.   

Abstract

Pompe disease (PD) is a recessive metabolic disorder characterized by acid α-glucosidase (GAA) deficiency, which results in lysosomal accumulation of glycogen in all tissues, especially in skeletal muscles. PD clinical course is mainly determined by the nature of the GAA mutations. Although ~400 distinct GAA sequence variations have been described, the genotype-phenotype correlation is not always evident.In this study, we describe the first clinical and genetic analysis of Colombian PD patients performed in 11 affected individuals. GAA open reading frame sequencing revealed eight distinct mutations related to PD etiology including two novel missense mutations, c.1106 T > C (p.Leu369Pro) and c.2236 T > C (p.Trp746Arg). In vitro functional studies showed that the structural changes conferred by both mutations did not inhibit the synthesis of the 110 kD GAA precursor form but affected the processing and intracellular transport of GAA. In addition, analysis of previously described variants located at this position (p.Trp746Gly, p.Trp746Cys, p.Trp746Ser, p.Trp746X) revealed new insights in the molecular basis of PD. Notably, we found that p.Trp746Cys mutation, which was previously described as a polymorphism as well as a causal mutation, displayed a mild deleterious effect. Interestingly and by chance, our study argues in favor of a remarkable Afro-American and European ancestry of the Colombian population. Taken together, our report provides valuable information on the PD genotype-phenotype correlation, which is expected to facilitate and improve genetic counseling of affected individuals and their families.

Entities:  

Year:  2012        PMID: 23430493      PMCID: PMC3575054          DOI: 10.1007/8904_2012_138

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  29 in total

1.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Authors:  Priya S Kishnani; Wuh-Liang Hwu; Hanna Mandel; Marc Nicolino; Florence Yong; Deyanira Corzo
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

2.  Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy.

Authors:  Alfred E Slonim; Linda Bulone; Teresia Goldberg; Jennifer Minikes; Efrat Slonim; Joseph Galanko; Frank Martiniuk
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

3.  The African origin of the common mutation in African American patients with glycogen-storage disease type II.

Authors:  J A Becker; J Vlach; N Raben; K Nagaraju; E M Adams; M M Hermans; A J Reuser; S S Brooks; C J Tifft; R Hirschhorn; M L Huie; M Nicolino; P H Plotz
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

4.  Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.

Authors:  M A Kroos; R J Pomponio; M L Hagemans; J L M Keulemans; M Phipps; M DeRiso; R E Palmer; M G E M Ausems; N A M E Van der Beek; O P Van Diggelen; D J J Halley; A T Van der Ploeg; A J J Reuser
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

5.  The identification of five novel mutations in the lysosomal acid a-(1-4) glucosidase gene from patients with glycogen storage disease type II. Mutations in brief no. 134. Online.

Authors:  C E Beesley; A H Child; M H Yacoub
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

6.  Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Online.

Authors:  N Raben; E Lee; L Lee; R Hirschhorn; P H Plotz
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

7.  Molecular genetic study of Pompe disease in Chinese patients in Taiwan.

Authors:  T M Ko; W L Hwu; Y W Lin; L H Tseng; H L Hwa; T R Wang; S M Chuang
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

8.  Delayed or late-onset type II glycogenosis with globular inclusions.

Authors:  Mehar C Sharma; Christoph Schultze; Arpad von Moers; Gisela Stoltenburg-Didinger; Yoon S Shin; Teodor Podskarbi; Klaus Isenhardt; Dominique S Tews; Hans H Goebel
Journal:  Acta Neuropathol       Date:  2005-06-29       Impact factor: 17.088

9.  Two mutations affecting the transport and maturation of lysosomal alpha-glucosidase in an adult case of glycogen storage disease type II.

Authors:  M M Hermans; M A Kroos; E de Graaff; B A Oostra; A J Reuser
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

10.  Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation.

Authors:  M L Huie; A S Chen; S Tsujino; S Shanske; S DiMauro; A G Engel; R Hirschhorn
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

View more
  7 in total

Review 1.  Molecular genetics of Pompe disease: a comprehensive overview.

Authors:  Paolo Peruzzo; Eleonora Pavan; Andrea Dardis
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.

Authors:  Gauthier Remiche; Dario Ronchi; Francesca Magri; Costanza Lamperti; Andreina Bordoni; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

3.  Selective screening for lysosomal storage diseases with dried blood spots collected on filter paper in 4,700 high-risk colombian subjects.

Authors:  Alfredo Uribe; Roberto Giugliani
Journal:  JIMD Rep       Date:  2013-04-23

4.  Clinical Laboratory Experience of Blood CRIM Testing in Infantile Pompe Disease.

Authors:  Deeksha S Bali; Jennifer L Goldstein; Catherine Rehder; Zoheb B Kazi; Kathryn L Berrier; Jian Dai; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2015-12-01

5.  A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan.

Authors:  Yasuyuki Fukuhara; Naoko Fuji; Narutoshi Yamazaki; Asami Hirakiyama; Tetsuharu Kamioka; Joo-Hyun Seo; Ryuichi Mashima; Motomichi Kosuga; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2017-10-31

6.  GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.

Authors:  Arnold J J Reuser; Ans T van der Ploeg; Yin-Hsiu Chien; Juan Llerena; Mary-Alice Abbott; Paula R Clemens; Virginia E Kimonis; Nancy Leslie; Sonia S Maruti; Bernd-Jan Sanson; Roberto Araujo; Magali Periquet; Antonio Toscano; Priya S Kishnani
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

7.  Incidence of infantile Pompe disease in the Maroon population of French Guiana.

Authors:  Narcisse Elenga; Alain Verloes; Yajaira Mrsic; Célia Basurko; Roxane Schaub; Emma Cuadro-Alvarez; Rémi Kom-Tchameni; Gabriel Carles; Véronique Lambert; Rachida Boukhari; Aniza Fahrasmane; Anne Jolivet; Mathieu Nacher; Jean-François Benoist
Journal:  BMJ Paediatr Open       Date:  2018-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.